tetano
Editor, Senior Moderator
J Community Health
. 2022 Jul 16.
doi: 10.1007/s10900-022-01118-z. Online ahead of print.
Pregnant and Postpartum Patients' Views of COVID-19 Vaccination
Lily Huang[SUP] 1 [/SUP], Kirsten A Riggan[SUP] 2 [/SUP], Grayson B Ashby[SUP] 3 [/SUP], Enid Y Rivera-Chiauzzi[SUP] 4 [/SUP], Megan A Allyse[SUP] 5 6 7 [/SUP]
Affiliations
Abstract
Perinatal patients were faced with the decision to receive a COVID-19 vaccination in the absence of clinical trial data on COVID-19 vaccine safety and efficacy in pregnant and lactating patients. We used the Coronavirus Perinatal Experiences Impact Survey to explore the impact of the COVID-19 pandemic on the lives of perinatal patients. The mixed-method survey was distributed to all patients ≥ 18 years old who were pregnant between January 1st, 2020 - April 28, 2021 at a large academic health system in the upper Midwest. Open-ended responses were qualitatively analyzed. Of the 1182 respondents who completed the survey, 647 answered at least one open-ended question. Among these 647 participants, 85 discussed COVID-19 vaccination and were secondarily analyzed. The responses illustrated a wide range of perspectives regarding COVID-19 vaccination, with many citing concerns over the consequences of maternal vaccination on their child. Others highlighted the lack of information surrounding COVID-19 vaccination in perinatal women. Respondents also discussed challenges discussing their vaccination status with their healthcare provider and the impact of family member's vaccination decisions on postpartum support and childcare. The unprompted discussion of concerns about COVID-19 vaccination suggests this decision weighed on many participants, especially in the context of lack of information early in the pandemic. Our findings support the need for open discussion of perinatal patients with their providers on COVID-19 vaccination during the pregnancy and postpartum period.
Keywords: Postnatal; Pregnancy; Qualitative research; Sars-Cov2; Vaccination.
. 2022 Jul 16.
doi: 10.1007/s10900-022-01118-z. Online ahead of print.
Pregnant and Postpartum Patients' Views of COVID-19 Vaccination
Lily Huang[SUP] 1 [/SUP], Kirsten A Riggan[SUP] 2 [/SUP], Grayson B Ashby[SUP] 3 [/SUP], Enid Y Rivera-Chiauzzi[SUP] 4 [/SUP], Megan A Allyse[SUP] 5 6 7 [/SUP]
Affiliations
- PMID: 35841461
- DOI: 10.1007/s10900-022-01118-z
Abstract
Perinatal patients were faced with the decision to receive a COVID-19 vaccination in the absence of clinical trial data on COVID-19 vaccine safety and efficacy in pregnant and lactating patients. We used the Coronavirus Perinatal Experiences Impact Survey to explore the impact of the COVID-19 pandemic on the lives of perinatal patients. The mixed-method survey was distributed to all patients ≥ 18 years old who were pregnant between January 1st, 2020 - April 28, 2021 at a large academic health system in the upper Midwest. Open-ended responses were qualitatively analyzed. Of the 1182 respondents who completed the survey, 647 answered at least one open-ended question. Among these 647 participants, 85 discussed COVID-19 vaccination and were secondarily analyzed. The responses illustrated a wide range of perspectives regarding COVID-19 vaccination, with many citing concerns over the consequences of maternal vaccination on their child. Others highlighted the lack of information surrounding COVID-19 vaccination in perinatal women. Respondents also discussed challenges discussing their vaccination status with their healthcare provider and the impact of family member's vaccination decisions on postpartum support and childcare. The unprompted discussion of concerns about COVID-19 vaccination suggests this decision weighed on many participants, especially in the context of lack of information early in the pandemic. Our findings support the need for open discussion of perinatal patients with their providers on COVID-19 vaccination during the pregnancy and postpartum period.
Keywords: Postnatal; Pregnancy; Qualitative research; Sars-Cov2; Vaccination.